Optimizing Antimicrobial Use: Antimicrobial Stewardship and Surveillance

Dear Colleagues,

The emergence and spread of multidrug-resistant (MDR) pathogens continue to threaten our ability to treat common infections, being considered a major threat for global health. During the last few decades, the implementation of antimicrobial stewardship programs has become more widespread in health centers. The objectives of these programs are to reduce the use of antimicrobials, reduce the duration of broad-spectrum antibiotic treatments, and to optimize individualized antibiotic treatment for the patient with the best efficacy and safety results, to slow down the advance of MDR pathogens. Even though there is ample evidence that the application of these multidisciplinary programs reduces the consumption of antimicrobials globally, the heterogeneity of the practices used and the unequal impact on the selection and infection by MDR strains make it essential to continue studying which interventions have a greater impact within these programs. This Special Issue seeks manuscript submissions that further our understanding of antimicrobial stewardship programs’ impact on bacterial resistance. Submissions on the impact of antimicrobial stewardship over bacterial resistance are especially encouraged.

Dr. Jesus Ruiz-Ramos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.